Meeting of the European Vision Institute - Special Interest Focus Group „New Technologies for Outcome Measures in Retina and Glaucoma” in Basel, Switzerland from 08. - 09. November 2018
How governments decide when to boost basic research funding, and when to scale back support.
The approval last year for the first autonomous artificial intelligence (AI) to make a diagnosis without a physician has opened new doors for the first medical device to use AI to diagnose moderate or worse diabetic retinopathy or macular edema in adults who have diabetes.
Software that uncovers suspicious papers will do little for a community that does not confront organized research fraud.
Many grant funding decisions are random, with luck playing a large part. How can the system be improved, particularly when funds are tight?
When it comes to fostering rigour and scientific integrity, US research institutions are stuck.
A newly released letter from a government watchdog has shed a little light on an ongoing U.S. government effort to scrutinize federally funded biomedical research for potentially problematic foreign involvement.
But researchers say the 25% increase is not enough to meet living costs.
The unique educational offering supports retina fellows during a weekend-long training at the Alcon Experience Center in Fort Worth, Texas.
Age-related macular degeneration (AMD) affects roughly 200,000 individuals in the United States each year.
Two studies reiterate that very few postdoctoral researchers land academic posts — and suggest that the skills postdocs learn are not sought by employers outside academia.
The approval of the DEXTENZA insert for surgical ocular pain was based on four phase Phase 3 studies one Phase 2 study for efficacy and safety.
Center for Vision and Population Health established to implement strategies in eye health
The Bausch + Lomb ULTRA® Multifocal for Astigmatism are monthly silicone hydrogel lenses designed for astigmatic correction.